-
11. BIBLIOMETRICS ANALYSIS OF RESEARCH PUBLICATIONS RELATED TO SUS SCROFA DOMESTICUS
JURNAL SAINS INSANI
2020 INDEX BY MYCITE 2019 MAIN AUTHOR -
12. RESEARCH ON BIDARA (ZIZIPHUS MAURITIANA): BIBLIOMETRIC STUDIES
JURNAL SAINS INSANI
2020 INDEX BY MYCITE 2019 CORRESPONDING AUTHOR -
13. RESEARCH PUBLICATIONS RELATED TO GOAT?S MILK: BIBLIOMETRICS ANALYSIS
JURNAL SAINS INSANI
2020 INDEX BY MYCITE 2019 MAIN AUTHOR -
14. SYSTEMATIC LITERATURE REVIEW ON CENTELLA ASIATICA
JURNAL SAINS INSANI
2020 INDEX BY MYCITE 2019 CO-AUTHOR -
15. METABOLITE PROFILING OF EPINEPHELUS FUSCOGUTTATUS INFECTED WITH VIBRIOSIS REVEALS OMEGA 9 AS POTENTIAL METABOLITE BIOMARKER.
FISH PHYSIOLOGY AND BIOCHEMISTRY
2019 ERA MAIN AUTHOR

ACADEMIC QUALIFICATIONS
- PhD in Systems Biology (2016)
- Bachelor in Biotechnology Industry (2008)
EXPERTISE
- Genetic Selection
- Fisheries Sciences
- Animal Products
- Animal Production And Conservation
- Biotechnology
DR. NURDALILA A'WANI BINTI ABD AZIZPENSYARAH UNIVERSITI DS13 Faculty Kolej Permata Insan Biography A lecturer from Kolej Permata Insan. Holds a Phd in Systems Biology. Usim Expert: https://expert.usim.edu.my/profile/nurdalila.awani Phone: 067980105 E-mail: nurdalila.awani@usim.edu.my |
RESEARCHER
ID
|
-
1. HALALTIFY DNA KIT
2024 GERAN PENYELIDIKAN PUSAT TANGGUNGJAWAB (PTJ) ON GOING MAIN RESEARCHER -
2. PENGUMPULAN GRAFIK INFO SAINS BAGI MANUSKRIP PERUBATAN MELAYU: KITAB TAYYIB AL-IHSAN FI TIBB AL-INSAN
2023 GERAN PENYELIDIKAN PUSAT TANGGUNGJAWAB (PTJ) ON GOING CO-RESEARCHER -
3. REMEDIES IN MALAY MEDICAL MANUSCRIPT MSS2515: ANALYSIS OF COMPOUND AND FUNCTION
2023 GERAN PENYELIDIKAN PUSAT TANGGUNGJAWAB (PTJ) ON GOING CO-RESEARCHER -
4. PROGRAM: EMPOWERING FOOD SECURITY IN MALAYSIA: A FRAMEWORK FOR TEMPORARY WAQF-BASED CROWDFUNDING FOR ALTERNATIVE PROTEINS ENTERPRISES PROJEK: HALAL GUIDELINES FOR ALTERNATIVE PROTEINS ENTERPRISES
2023 GERAN PENYELIDIKAN TRANSDISIPLINARI ON GOING CO-RESEARCHER -
5. UNDERLYING MICROBIAL COMMUNITY AND ITS TYPES OF GROUND DUST
2022 BIDUNI MIZANNIYAH ON GOING MAIN RESEARCHER
Completed: 3 (33%)
Ongoing: 6 (67%)